We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-7.64%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$563M
AUM Growth
-$101M
(-15%)
Cap. Flow
-$27M
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
25.13%
Holding
123
New
15
Increased
30
Reduced
43
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$13.2M |
| 2 |
HealthEquity
HQY
|
+$13M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$7.95M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$7.45M |
| 5 |
ITOS
iTeos Therapeutics
ITOS
|
+$5.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$21.4M |
| 2 |
Alignment Healthcare
ALHC
|
+$10.3M |
| 3 |
Definitive Healthcare
DH
|
+$7.8M |
| 4 |
TG Therapeutics
TGTX
|
+$7.6M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
+$6.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.69% |
| 2 | Industrials | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$385B
| $16.7M | 2.96% |
32,700
+2,400
| +8% | +$1.16M |
|
|
2
HealthEquity
HQY
$7.89B
| $16.2M | 2.87% |
+240,000
| New | +$13M |
|
|
NARI
3
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $14.6M | 2.59% |
161,060
-2,490
| -2% | -$204K |
|
4
AtriCure
ATRC
$1.67B
| $14.3M | 2.54% |
218,164
-13,050
| -6% | -$846K |
|
|
SYNH
5
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $14.3M | 2.53% |
176,306
+12,050
| +7% | +$1.02M |
|
|
RCM
6
DELISTED
R1 RCM Inc. Common Stock
RCM
| $14.1M | 2.51% |
528,494
-79,000
| -13% | -$1.94M |
|
7
Inspire Medical Systems
INSP
$1.46B
| $13.3M | 2.35% |
51,650
| – | – |
|
8
Johnson & Johnson
JNJ
$624B
| $12.9M | 2.29% |
72,750
-1,750
| -2% | -$298K |
|
9
Evolent Health
EVH
$522M
| $12.7M | 2.25% |
392,142
-159,859
| -29% | -$4.19M |
|
|
BHVN
10
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.6M | 2.23% |
+105,850
| New | +$13.2M |
|
11
Insmed
INSM
$23.3B
| $12.4M | 2.2% |
528,342
| – | – |
|
|
OCDX
12
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $12.4M | 2.2% |
665,347
-205,000
| -24% | -$3.69M |
|
13
Tenet Healthcare
THC
$17.1B
| $12.3M | 2.18% |
143,000
| – | – |
|
14
Arvinas
ARVN
$524M
| $11.2M | 1.98% |
166,131
-12,082
| -7% | -$823K |
|
15
Arcus Biosciences
RCUS
$3.74B
| $10.7M | 1.9% |
338,480
+55,270
| +20% | +$1.85M |
|
|
AGTI
16
DELISTED
Agiliti Inc
AGTI
| $10.1M | 1.8% |
479,647
+29,900
| +7% | +$565K |
|
17
Thermo Fisher Scientific
TMO
$213B
| $9.88M | 1.75% |
16,725
-425
| -2% | -$244K |
|
18
PTC Therapeutics
PTCT
$6.51B
| $9.86M | 1.75% |
264,391
+2,100
| +0.8% | +$80.9K |
|
19
AbbVie
ABBV
$454B
| $9.78M | 1.74% |
60,300
-8,500
| -12% | -$1.23M |
|
20
Privia Health
PRVA
$3.15B
| $9.66M | 1.72% |
361,550
-40,079
| -10% | -$946K |
|
21
Pfizer
PFE
$143B
| $9.57M | 1.7% |
184,900
-23,500
| -11% | -$1.22M |
|
|
EFTR
22
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $9.55M | 1.7% |
95,310
| – | – |
|
|
23
Tandem Diabetes Care
TNDM
$1.16B
| $9.26M | 1.64% |
79,588
+63,813
| +405% | +$7.45M |
|
|
SILK
24
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.63M | 1.53% |
209,000
| – | – |
|
25
Exelixis
EXEL
$14B
| $8.25M | 1.46% |
363,840
-46,100
| -11% | -$900K |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Sectoral Asset Management held 123 positions worth $563M, down 15% from $664M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management withdrew a net $27M in Q1 2022, closing 17 positions and reducing 43 holdings. Its most notable exit was Arena Pharmaceuticals Inc, an estimated $21.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in Biohaven Pharmaceutical Holding Company Ltd. worth $12.6M.
- Sectoral Asset Management's largest Q1 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 105,850 shares worth $12.6M.
- Sectoral Asset Management added most to BioMarin Pharmaceuticals in Q1 2022, an estimated $7.95M increase.
- Sectoral Asset Management's biggest Q1 2022 reduction was Amicus Therapeutics, cutting an estimated $5.8M.
- Sectoral Asset Management fully exited Arena Pharmaceuticals Inc in Q1 2022, selling an estimated $21.4M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $563M portfolio in Q1 2022.
- Sectoral Asset Management opened 15 new positions and closed 17 in Q1 2022.
- Sectoral Asset Management's portfolio value fell 15% quarter-over-quarter to $563M.
Based on Sectoral Asset Management's 13F filing for Q1 2022, filed 10 May 2022.